期刊文献+

华法林导致老年气管支气管弥漫性钙化1例并文献复习

Warfarin-induced diffuse tracheobronchial calcification in elderly patients:a case report and literature review
下载PDF
导出
摘要 目的报道1例长期口服华法林导致弥漫性气管支气管钙化的病例,结合相关文献复习对华法林导致气管支气管钙化的病例特点、作用机制以及新型抗凝药物的替代进行阐述。方法以“tracheobronchial calcification,warfarin”为检索词,在PubMed数据库检索2021年8月之前所有报道,共8篇文献,成年患者以个案报道的3例以及有关华法林导致气管支气管钙化病例对照研究1篇;在万方数据库以“气管支气管(弥漫性)钙化、华法林”为检索词,检索2021年8月之前所有报道的国内病例,检索到相关文献1篇;在中国知网数据库以“气管支气管(弥漫性)钙化、华法林”为检索词,检索到相关文献1篇。结果本文报道1例77岁老年女性患者,口服华法林20年,胸部CT检查示气管、支气管弥漫性钙化,支气管镜显示气管和支气管无结节样凸起。气管支气管钙化在老年患者中较常见,成年患者中由华法林导致的气管支气管弥漫性钙化较少见,女性居多,无特殊临床和影像学特点。结论长期口服华法林可导致气管支气管弥漫性钙化,目前因无明显临床症状未受重视,所以低估了该疾病的患病率,日后需加强临床及放射科医生对此类患者的肺部影像学随访。 Objective To report a case of diffuse tracheobronchial calcification caused by long-term oral warfarin,and describe the case characteristics,mechanism of action and substitution of new anticoagulant drugs based on the review of relevant literature.Methods Take"traceobronchial calibration,warfarin"as the search words,all literatures reported in PubMed Database before August 2021 were searched.There were 8 articles in total,including 3 individual case reports of adult patients and 1 case-control study on warfarin-induced tracheobronchial calcification.Take"tracheobronchial(diffuse)calcification and warfarin"as the search words,all domestic literatures reported in Wanfang Database before August2021 were searched.1 related article was retrieved.Taking"tracheobronchial(diffuse)calcification and warfarin"as the search words in CNKI Database,1 relevant article was retrieved.Results This paper reported a case of a 77 year old female patient who had taken warfarin for 20 years.Chest CT showed diffuse calcification of the trachea and bronchi,and bronchoscopy showed no nodular protrusions in the trachea and bronchi.Tracheobronchial calcification was more common in elderly patients.Diffuse tracheobronchial calcification caused by warfarin was rare in adult patients,mostly in women,without special clinical and imaging features.Conclusion Long-term oral warfarin can cause diffuse tracheobronchial calcification.At present,the prevalence of the disease is underestimated because there are no obvious clinical symptoms.In the future,it is necessary to strengthen the follow-up of lung imaging in such patients by clinicians and radiologists.
作者 张诚实 崔栋慧 冯契靓 张青 鲁晓怡 赵云峰 雷撼 杨晓荣 Zhang Chengshi;Cui Donghui;Feng Qiliang;Zhang Qing;Lu Xiaoyi;Zhao Yunfeng;Lei Han;Yang Xiaorong(Department of Respiratory,Punan Hospital,Pudong New District,Shanghai,200125,P.R.China;Department of Endocrinology,Zhoupu Hospital Affiliated to Shanghai College of Medicine&Health Science,Shanghai,201318,P.R.China)
出处 《老年医学与保健》 CAS 2022年第2期296-299,304,共5页 Geriatrics & Health Care
基金 浦东新区卫生系统重点亚专科建设资助(PWZy2020-15) 浦东新区优秀青年医学人才培养计划(PWRq2020-46) 浦东新区科委课题资助(PKJ2021-Y87)。
关键词 老年 气管支气管钙化 华法林 维生素K拮抗剂 elderly tracheobronchial calcification warfarin vitamin K antagonist
  • 相关文献

参考文献4

二级参考文献41

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652.
  • 3Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146:S57-867.
  • 4Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coil Cardiol, 2008, 52: 865-868.
  • 5Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005,352:2285-2293.
  • 6Aithal GP, Day CP, Kesteven PJ, et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 1999, 353:717-719.
  • 7Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :eddS- 88S.
  • 8Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :e152S-184S.
  • 9Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics, 2010, 11 : 493 -496.
  • 10Schulman S, Parpia S, Stewart C, et al. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med, 2011,155:653-659.

共引文献596

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部